EUVIMEDEUVIMED entdecken
Crossref

Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm

Ali Ikhsanul Qauli, Nurul Qashri Mahardika T, Ulfa Latifa Hanum, Frederique Jos Vanheusden, Ki Moo Lim

Computer Methods and Programs in Biomedicine · 2025

DOI: 10.1016/j.cmpb.2025.108609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Computer Methods and Programs in Biomedicine, 2025. Verfasst von Ali Ikhsanul Qauli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kumoh National Institute of Technology, IT convergence engineering, Gumi 39177, Republic of Korea; Universitas Airlangga, Faculty of Advanced Technol…. Hauptthemen laut MEDLINE: Algorithms, Biomarkers, Arrhythmias, Cardiac, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Using electrophysiological simulations and machine learning to predict drug proarrhythmia risk has gained popularity due to its effectiveness. The leading in silico drug assessment system mainly uses a single biomarker (qNet) to predict proarrhythmia risk, offering good performance and straightforward interpretation. Other advanced classifiers incorporating additional physiological biomarkers provide better predictive capabilities but are less intuitive. Thus, a method that accommodates multiple biomarkers while maintaining interpretability is needed. METHODS: We enhance the current best ordinal logistic regression (OLR) model by adding more physiological biomarkers to overcome its limitations. We also introduce a general torsade metric score (TMS) for multi-biomarker approaches to facilitate easier interpretation. Additionally, a novel ranking algorithm based on a simple multi-criteria decision analysis method is employed to evaluate various classifiers against standard proarrhythmia risk criteria efficiently. RESULTS: Our proposed method demonstrates that using multiple well-known biomarkers yields better performance than using qNet alone. Some accepted multi-biomarker OLR models do not incorporate qNet yet outperform those that do. Moreover, some ill-performing biomarkers when utilized individually can show improved performance in combination with other biomarkers. CONCLUSION: The proposed approach offers an effective way of utilizing multiple biomarkers, including well-known ones, providing practical alternatives for proarrhythmia risk assessment. The interpretability of the accepted models is straightforward, thanks to the TMS thresholds for multi-biomarker OLR models that allow direct evaluation of the classification prediction of individual drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsBiomarkersArrhythmias, CardiacDrug-Related Side Effects and Adverse ReactionsHumansComputer SimulationRisk AssessmentMachine LearningLogistic Models

Stichwörter der Autor:innen

BiomarkerDrugMulti-criteria decision analysisOrdinal logistic regressionProarrhythmia riskSimulation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Kumoh National Institute of Technology, IT convergence engineering, Gumi 39177, Republic of Korea; Universitas Airlangga, Faculty of Advanced Technology and Multidiscipline, Department of Engineering, Surabaya, Indonesi…
  • Kumoh National Institute of Technology, IT convergence engineering, Gumi 39177, Republic of Korea.
  • School of Science & Technology, Nottingham Trent University, United Kingdom.
  • Kumoh National Institute of Technology, IT convergence engineering, Gumi 39177, Republic of Korea; Kumoh National Institute of Technology, Medical IT convergence engineering, Gumi 39253, Republic of Korea; Meta Heart In…

Zitieren

APA

Qauli, A. I., T, N. Q. M., Hanum, U. L., Vanheusden, F. J., & Lim, K. M. (2025). Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm. Computer Methods and Programs in Biomedicine. https://doi.org/10.1016/j.cmpb.2025.108609

Vancouver

Qauli AI, T NQM, Hanum UL, Vanheusden FJ, Lim KM. Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm. Computer Methods and Programs in Biomedicine. 2025. doi:10.1016/j.cmpb.2025.108609

BibTeX
@article{Qauli2025,
  author = {Qauli, Ali Ikhsanul and T, Nurul Qashri Mahardika and Hanum, Ulfa Latifa and Vanheusden, Frederique Jos and Lim, Ki Moo},
  title = {Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm},
  journal = {Computer Methods and Programs in Biomedicine},
  year = {2025},
  doi = {10.1016/j.cmpb.2025.108609}
}
Kostenlos starten →